Home > News > Labopharm reports results for third quarter fiscal 2004
October 28th, 2004
Labopharm reports results for third quarter fiscal 2004
Abstract:
Labopharm Inc. (TSX: DDS) today reported its results for the third quarter of fiscal 2004 ended
September 30, 2004. Net loss for the third quarter of fiscal 2004 was $5.9 million, or $0.14
per share, compared with $7.9 million, or $0.22 per share, for the third quarter of fiscal 2003.
Source:
prnewswire
Related Links |
Related News Press |
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||